The Biotech Growth Trust PLC Working Capital to Net Assets Ratio
The Biotech Growth Trust PLC working capital to net assets ratio. The Biotech Growth Trust PLC (BIOG) has a Working Capital to Net Assets ratio of 3.6% as of March 2025. Working capital of GBX8.06 Million (current assets of GBX8.47 Million minus current liabilities of GBX405.00K) is measured against net assets of GBX221.21 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of The Biotech Growth Trust PLC to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of The Biotech Growth Trust PLC (2004–2025)
Working capital to net assets ratio of The Biotech Growth Trust PLC from 2004 to 2025. This chart shows how The Biotech Growth Trust PLC's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2004 to 2025. As of March 2025, the ratio stands at 3.6%, reflecting working capital of GBX8.06 Million against net assets of GBX221.21 Million GBX. See The Biotech Growth Trust PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
The Biotech Growth Trust PLC Working Capital to Net Assets Ratio by Year (2004–2025)
The Biotech Growth Trust PLC working capital to net assets ratio by year from 2004 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for The Biotech Growth Trust PLC from 2004 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see The Biotech Growth Trust PLC asset portfolio.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.6% | GBX8.06 Million | GBX221.21 Million | GBX8.47 Million | GBX405.00K | ▲ +13.6 pp |
| 2024 | -9.9% | GBX-35.85 Million | GBX361.31 Million | GBX16.67 Million | GBX52.52 Million | ▼ -1.8 pp |
| 2023 | -8.2% | GBX-26.94 Million | GBX330.29 Million | GBX3.28 Million | GBX30.22 Million | ▲ +0.3 pp |
| 2022 | -8.4% | GBX-33.19 Million | GBX394.21 Million | GBX49.00K | GBX33.24 Million | ▼ -1.5 pp |
| 2021 | -7.0% | GBX-41.80 Million | GBX601.47 Million | GBX6.26 Million | GBX48.06 Million | ▲ +2.1 pp |
| 2020 | -9.0% | GBX-33.08 Million | GBX365.57 Million | GBX2.53 Million | GBX35.62 Million | ▼ -3.6 pp |
| 2019 | -5.5% | GBX-22.30 Million | GBX408.88 Million | GBX60.00K | GBX22.36 Million | ▼ -4.2 pp |
| 2018 | -1.2% | GBX-5.02 Million | GBX417.40 Million | GBX387.00K | GBX5.41 Million | ▲ +2.0 pp |
| 2017 | -3.2% | GBX-14.30 Million | GBX448.41 Million | GBX15.00K | GBX14.32 Million | ▼ -1.9 pp |
| 2016 | -1.3% | GBX-4.76 Million | GBX378.57 Million | GBX4.58 Million | GBX9.34 Million | ▼ -1.6 pp |
| 2015 | 0.3% | GBX1.62 Million | GBX533.30 Million | GBX3.20 Million | GBX1.58 Million | ▼ -0.1 pp |
| 2014 | 0.4% | GBX1.47 Million | GBX340.25 Million | GBX11.90 Million | GBX10.43 Million | ▲ +0.4 pp |
| 2013 | 0.0% | GBX74.00K | GBX244.44 Million | GBX22.29 Million | GBX22.22 Million | ▲ +3.6 pp |
| 2012 | -3.5% | GBX-5.52 Million | GBX156.13 Million | GBX213.00K | GBX5.74 Million | ▲ +2.7 pp |
| 2011 | -6.2% | GBX-7.53 Million | GBX120.82 Million | GBX6.85 Million | GBX14.38 Million | ▼ -3.1 pp |
| 2010 | -3.1% | GBX-3.71 Million | GBX120.42 Million | GBX304.00K | GBX4.02 Million | ▼ -6.1 pp |
| 2009 | 3.0% | GBX2.09 Million | GBX70.21 Million | GBX3.23 Million | GBX1.14 Million | ▲ +3.2 pp |
| 2007 | -0.2% | GBX-192.00K | GBX76.80 Million | GBX2.44 Million | GBX2.63 Million | ▼ -2.1 pp |
| 2006 | 1.8% | GBX662.00K | GBX36.56 Million | GBX2.02 Million | GBX1.36 Million | ▲ +1.7 pp |
| 2005 | 0.2% | GBX46.00K | GBX30.45 Million | GBX340.00K | GBX294.00K | ▲ +0.5 pp |
| 2004 | -0.4% | GBX-131.00K | GBX33.62 Million | GBX331.00K | GBX462.00K | — |